MDA-MB-231 Cell Line human

92020424, human breast, Epithelial

• Synonyme(s) : MD Anderson-Metastatic Breast-231 Cells, MDA-MB231 Cells, MDA231-BRE Cells, MDAMB231 Cells
• Code UNSPSC : 41106514
• eCl@ss : 32190102

Propriétés

• product name: MDA-MB-231 Cell Line human, human breast adenocarcinoma, 92020424
• Source biologique: human breast
• Mode de croissance: Adherent
• Caryotype: Modal no.′s 62 and 64, near triploid
• Morphologie: Epithelial
• Produits: Not specified
• Récepteurs: Not specified
• Technique(s): cell culture | mammalian: suitable
• Maladie(s) pertinente(s): cancer
• Conditions d'expédition: dry ice
• Température de stockage: −196°C

Description

Origine de la lignée cellulaire

Human Caucasian breast adenocarcinoma

Description de la lignée cellulaire

Isolated from pleural effusions of a breast cancer patient.

Application

MDA-MB-231 has been used to study:

• the changes in the morphological pattern and gene expression of cells when grown in the presence of sera positive for anti-carbonic anhydrase I (CA I) autoantibodies
• the effects of normothermic conditioned microwave irradiation on cultured cells using an irradiation system
• the transendothelial migration rates of the cells under different shear stress levels

Profil d'ADN

STR-PCR Data: Amelogenin: X
CSF1PO: 12,13
D13S317: 13
D16S539: 12
D5S818: 12
D7S820: 8,9
THO1: 7,9.3
TPOX: 8,9
vWA: 15,18

Milieu de culture

L15+ 2mM Glutamine + 15% Foetal Bovine SerumFBS / FCS.

Procédure de repiquage

Split sub-confluent cultures (70-80%) 1:3 to 1:6, i.e. seeding at 3-6x10,000 cells/cm² using 0.05% Trypsin or Trypsin/EDTA; 37°C. CO₂ is not required.

Autres remarques

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

Clause de non-responsabilité

This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form.